Skip to main content
SpringerLink
Log in

Method of Resection of Branch-Duct IPMN

  • Chapter
  • First Online:
Intraductal Papillary Mucinous Neoplasm of the Pancreas

  • 910 Accesses

Abstract

IPMNs of the pancreas are precursor lesions to pancreatic ductal adenocarcinoma. The risk of malignancy in IPMN is based on further subclassification into three types: main-duct IPMN (MD-IPMN), branch-duct IPMN (BD-IPMN), and mixed-type IPMN (MT-IPMN). The malignant potential of MD and MT is substantial and most should undergo resection. The BD-IPMN subtype is more indolent and the decision to resect is more selective. The international consensus guidelines for the management of cystic neoplasms known as the “Sendai criteria” or “Tanaka criteria” provide recommendations for the management of BD-IPMN based on risk of malignancy. Indications for resection of BD-IPMN include the high-risk stigmata of jaundice and the presence of a solid component. Since the decision to resect IPMN is based on concern for malignancy, a formal oncological operation should be performed. The outcome of resected benign BD-IPMN is good. However, the risk of progressive or new IPMN disease, including invasive cancer, in patients undergoing resection of BD-IPMN is significant, and these individuals need to be followed closely and indefinitely.

Disclosures: Neither author has any disclosures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Cauley CE, Waters JA, Dumas RP, et al. Outcomes of primary surveillance for intraductal papillary mucinous neoplasm. J Gastrointest Surg. 2012;16(2):258–67. discussion 266.

    Article  PubMed  Google Scholar 

  • Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123(5):1500–7.

    Article  PubMed  Google Scholar 

  • Correa-Gallego C et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology. 2010;10(2–3):144–50.

    Article  PubMed  Google Scholar 

  • Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol. 2003;98:1516–24.

    Article  PubMed  Google Scholar 

  • He J, Cameron JL, Ahuja N, Makary MA, Hirose K, Choti MA, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216(4):657–65.

    Article  PubMed  Google Scholar 

  • Hwang DW, Jang JY, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg. 2012;397:93–102.

    Article  PubMed  Google Scholar 

  • Kang MJ, Jang JY, Kim SJ, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 2011;9:87–93.

    Article  PubMed  Google Scholar 

  • Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc. 2009;69:1095–102.

    Article  PubMed  Google Scholar 

  • Levy P, Jouannaud V, O'Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4:460–8.

    Article  PubMed  Google Scholar 

  • Miller JR, Meyer JE, Waters JA, et al. Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford). 2011;13(11):759–66.

    Article  Google Scholar 

  • Moriya T, Traverso W. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study. Arch Surg. 2012;147(6):528–34.

    Article  PubMed  Google Scholar 

  • Nagai K, Doi R, Kida A, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg. 2008;32:271–8. discussion 279–80.

    Article  PubMed  Google Scholar 

  • Rodriguez JR et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133(1):72–9. quiz 309–10.

    Article  PubMed  Google Scholar 

  • Sadakari Y et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas. 2010;39(2):232–6.

    Article  PubMed  Google Scholar 

  • Sahani DV, Kadavigere R, Saokar A, et al. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics. 2005;25:1471–84.

    Article  PubMed  Google Scholar 

  • Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–85. discussion 685–7.

    Article  PubMed  Google Scholar 

  • Sawhney MS, Devarajan S, O'Farrel P, et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc. 2009;69:1106–10.

    Article  PubMed  Google Scholar 

  • Shen J, Brugge WR, Dimaio CJ, et al. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer. 2009;117:217–27.

    PubMed  Google Scholar 

  • Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–97. discussion 797–9.

    Article  PubMed  Google Scholar 

  • Sreenarasimhaiah J, Lara LF, Jazrawi SF, et al. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. JOP. 2009;10:163–8.

    PubMed  Google Scholar 

  • Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas. 2004;28:241–6.

    Article  PubMed  Google Scholar 

  • Tanaka M et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6(1–2):17–32.

    Article  PubMed  Google Scholar 

  • Tanaka M, Fernandez-Del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.

    Article  PubMed  Google Scholar 

  • Turrini O et al. Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation? HPB (Oxford). 2011;13(2):126–31.

    Article  Google Scholar 

  • van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005;62:383–9.

    Article  PubMed  Google Scholar 

  • White R, D'Angelica M, Katabi N, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204(5):987–93. discussion 993–985.

    Article  PubMed  Google Scholar 

  • Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Johns Hopkins Hospital, Baltimore, MD, USA

    Anne Marie Lennon & Christopher L. Wolfgang

Authors
  1. Anne Marie Lennon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher L. Wolfgang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher L. Wolfgang .

Editor information

Editors and Affiliations

  1. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan

    Masao Tanaka

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Lennon, A.M., Wolfgang, C.L. (2014). Method of Resection of Branch-Duct IPMN. In: Tanaka, M. (eds) Intraductal Papillary Mucinous Neoplasm of the Pancreas. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54472-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54472-2_13

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54471-5

  • Online ISBN: 978-4-431-54472-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation